ALLARITY THERAPEUTICS, INC. SECURITY AGREEMENTSecurity Agreement • November 25th, 2022 • Allarity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 25th, 2022 Company Industry JurisdictionThis Security Agreement (this “Agreement”) is made as of November 23, 2022, by Allarity Therapeutics, Inc, a Delaware corporation (the “Company”), in favor of 3i, LP a Delaware limited partnership (the “Holder”).
ALLARITY THERAPEUTICS, INC. SECURED NOTE PURCHASE AGREEMENTSecured Note Purchase Agreement • November 25th, 2022 • Allarity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 25th, 2022 Company Industry JurisdictionThis Secured Note Purchase Agreement dated as of November 22, 2022 (this “Agreement”), is entered into by and among Allarity Therapeutics, Inc. (the “Company”), and the entity listed on the schedule of investors attached hereto as Schedule I (the “Investor”).